
Amaros AI is a deep tech company founded in 2018 in Silicon Valley that delivers precision intelligence to transform ophthalmic care. Its proprietary EvidenceEngine platform integrates fragmented ophthalmic data from EMRs, multimodal images, genetics, provider notes, and payor claims into structured, real-time insights. Amaros serves clinics, CROs, and therapeutic teams by enabling smarter clinical trials, personalized care, and commercial growth through AI-powered analytics and biomarker tracking. The platform accelerates clinical trial enrollment, enhances protocol execution, and reveals access gaps and growth opportunities, positioning Amaros as a category creator in ophthalmology intelligence ecosystems.

Amaros AI is a deep tech company founded in 2018 in Silicon Valley that delivers precision intelligence to transform ophthalmic care. Its proprietary EvidenceEngine platform integrates fragmented ophthalmic data from EMRs, multimodal images, genetics, provider notes, and payor claims into structured, real-time insights. Amaros serves clinics, CROs, and therapeutic teams by enabling smarter clinical trials, personalized care, and commercial growth through AI-powered analytics and biomarker tracking. The platform accelerates clinical trial enrollment, enhances protocol execution, and reveals access gaps and growth opportunities, positioning Amaros as a category creator in ophthalmology intelligence ecosystems.